9 August 2017

Presented by: Fabien Ricard, MD, Medical Director and Catherine Klifa, PhD, Science Liaison

Medical imaging is an integral component of clinical trials in oncology. For each image type, quantifiable information (biomarkers) can be extracted and analyzed to potentially answer questions about tumor types and stage, and to measure any sign of response to treatment. The most common assessment of response to therapy is to measure anatomical changes to the tumor with treatment. Other quantitative imaging measures derived from functional imaging methods provide equally important physiological information about a tumor, including tumor metabolism, vascularity, and cellularity.

What you will learn in this webinar:
– The difference between qualitative and quantitative biomarkers
– Definition of treatment response criteria
– Various types of measurement: morphological and volumetric
– Functional imaging measurements by modality
– Measurements by cancer/treatment type